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Abstract Chemical genetics is an emerging field
that can be used to study the interactions of chemical
compounds, including natural products, with proteins.
Usually, the identification of molecular targets is the
starting point for studying a drug’s mechanism of
action and this has been a crucial step in understanding
many biological processes. While a great variety of
target identification methods have been developed
over the last several years, there are still many
bioactive compounds whose target proteins have not
yet been revealed because no routine protocols can be
adopted. This review contains information concerning
the most relevant principles of chemical genetics with
special emphasis on the different genomic and
proteomic approaches used in forward chemical
genetics to identify the molecular targets of the
bioactive compounds, the advantages and disadvan-
tages of each and a detailed list of successful examples
of molecular targets identified with these approaches.
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Despite advances made in combinatorial chemistry
techniques (Lebl 1999) and high throughput screening
(HTS) (Fox et al. 1999) by the pharmaceutical industry
which have provided a greater number of novel
chemical compounds and related biological data
(Oprea 2002), the number of new drugs developed or
under clinical trial has not increased proportionately
(Bronson et al. 2011; Danishefsky 2010; Drews 2000;
Gaudillière et al. 2001; Horrobin 2000).
Modern medicinal chemistry is focused on the
study of protein-small molecule interactions and gene
functionalities encoding protein synthesis (Stockwell
2004). Many of the medicinally relevant proteins have
already been identified and in this connection the
sequencing of the human genome (Drews 2000;
Witkowski 2010) has helped scientists to identify
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therapeutic targets and tackle the diseases facing
humanity. However, elucidation of bioactive com-
pound mechanisms of action is the major problem in
chemical biology (Kwok et al. 2006) since most
cellular targets of bioactive compounds have yet to be
revealed. Natural products (NPs) are now increasingly
being used as probes in the systematic search of
inhibitors for key biochemical pathways and to delve
further into the study of biological systems (Carlson
2010). The efficient identification of the chemical
compounds that modulate protein functions both
in vivo and in vitro is at the heart of research in
chemical biology and medicinal chemistry.
Small molecules (SM) are essential as drugs in
modern medicine and are valuable as probes to explore
relevant biological processes. However, new
approaches are needed to close the wide gap between
the ability to study either single proteins or whole
cellular processes. So, it is of interest to focus on
studies designed to understand in more detail how SM
disrupt particular signalling pathways and larger
networks to yield distinct cellular phenotypes (Casto-
reno and Eggert 2011).
Chemical genetics
Chemical biology includes study and research of the
interface between chemistry and biology (Altmann
et al. 2009). In this context, chemical biology is aimed
at studying the interactions of chemical compounds,
including NPs, with proteins, to identify their role in
biological processes (Schreiber 2003).
The above definition of chemical biology comple-
ments classical genetics where the focus is also on
finding targets and signalling pathways. Chemical
genetics can be defined simply as a genetic study using
chemical tools (Schreiber 1998). Chemical genetics
uses chemical compounds that may specifically acti-
vate or inhibit one or more target proteins (Chang
2009; Spring 2005). It offers several advantages over
its classical counterpart and allows the study of
unexplored biological space. For example, genes
essential for survival or development cannot be
studied using classical genetics; this can only be done
using chemical genetics. Thus, the instantaneous
effects of SM can be characterized using chemical
genetics (Chang 2009; Walsh and Chang 2006). It also
makes it possible to study mammals whereas classical
genetic techniques are more complicated to apply due
to their diploid genome, physical size and slow
reproduction rate (Chang 2009). Other benefits of
using chemical compounds are the temporal control
and reversibility of the inhibition of protein function
(Hübel et al. 2008).
As in classical genetics, two approaches can be
taken to chemical genetics (Fig. 1) (Das et al. 2011):
Forward chemical genetics (Chang 2009; Burdine and
Kodadek 2004) and reverse chemical genetics (Black-
well and Zhao 2003; Neumann et al. 2003).
In forward chemical genetics, typical random
mutagenesis is replaced by a screening of a library of
typically not targeted SMs against multiple potential
targets simultaneously (Chang 2009). Compounds that
induce a phenotype of interest can be selected and then
the target protein of this compound is identified.
Forward chemical genetics require three components
(Lokey 2003): (a) a collection or library of chemical
compounds (chemical toolbox generation); (b) a bio-
logical assay with a quantifiable phenotypic output,
usually performed using living cells or complex
cellular extracts by means of the cyclobot method
(Mendoza et al. 1999; Stockwell et al. 1999) and (c) a
strategy to join an active compound to its biological
target, otherwise known as target identification.
In reverse chemical genetics, a known target
protein is screened using SM libraries to identify
functional ligands that either stimulate or inhibit the
target protein. Once a specific ligand that produces a
change in the protein function is identified, it is
introduced into a cell or organism and the resulting
changes in the phenotype are studied (Chang 2009).
Thus, chemical genetics work in reverse, i.e. from
genotype to phenotype, while in forward chemical
genetics the direction is from phenotype to genotype
(Spring 2005).
Fig. 1 Approaches in chemical genetics
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Today, target identification is one of the greatest
challenges in forward chemical genetics. Recent
progress and difficulties in this field and different
methods for the identification of biological targets will
be discussed in depth in this review.
Approaches to the biological target identification
in forward chemical genetics
Once a SM that induces a certain phenotypic response
in a cell culture or in vivo experiment has been
identified, the elucidation of it biological target is one
of the greatest technical challenges in forward chem-
ical genetics and phenotype-based drug discovery.
The determination of these targets is particularly
important in understanding the mode of action of
potential SM and of various biological processes under
study since a large number of drugs have multiple
intracellular targets, some of which may be responsi-
ble for the undesirable side effects of the drugs.
Therefore, identification of relevant targets can often
lead to the discovery of more specific drugs with fewer
side effects (Campillos et al. 2008). Furthermore, once
a target protein is identified, its functions and cellular
signalling pathways can be elucidated thus facilitating
drug discovery research. However, no routine proto-
cols can be adopted for the identification of molecular
targets due to the great structural diversity of NPs.
Over the last several years a great variety of target
identification methods have been developed, ranging
from biochemical to genetic, which have received a
number of excellent reviews (Das et al. 2011; Hübel
et al. 2008; Leslie and Hergenrother 2008; Roti and
Stegmaier 2012; Sleno and Emili 2008; Terstappen et al.
2007). We will classify these approaches as: affinity-
based methods, genetic methods and other methods.
Affinity-based target identification methods
Traditionally, affinity-based methods play a major role
in the identification of molecular targets for many
biologically-active SM and NPs. These methods
detect the direct binding of the SM to its target(s) and
almost all successful affinity experiment have
involved the combination of high affinity molecules
with a high abundance of target proteins such as the
isolation of FKBP12 (FK-506 binding protein-12)
using the compound FK506 (Harding et al. 1989).
However, it is possible to isolate a high abundance
target protein with a low-affinity SM since, although
interaction affinity is low, the abundance of the target
proteins enable identification, a case in hand being the
isolation of human GLO1 (glyoxalase 1) as a second-
ary target of the anti-inflammatory SM indomethacin
(Sato et al. 2007).
We will classify the affinity-based target identifi-
cation methods in the following groups: Matrix-based
affinity methods: Affinity chromatography; Matrix-
free affinity methods: Affinity by fluorescence, radio-
activity, photoaffinity or immunoaffinity; Methods
based on the stability of the target in response to its
affinity for the drug (DARTS); Mass spectrometry-
based affinity techniques and stability of proteins of
rates of oxidation (SPROX).
Matrix-based affinity methods: affinity
chromatography
Affinity chromatography is the oldest and most widely
and successful used approach (Guiffant et al. 2007;
Katayama and Oda 2007; Sakamoto et al. 2012; Sato
et al. 2010). In this method a SM of interest is modified
by introducing a suitable functional group (linker)
through which it can be immobilized by attachment to
a solid support (matrix) followed by the addition of a
protein extract. Matrix-based methods should fulfil
three requisites: (a) that the SM contains a derivatiz-
able function, (b) that SM retains at least part of their
activity after the derivatization and (c) that the matrix
does not hinder the binding of the target protein to the
SM (Lomenick et al. 2009). The latter two conditions
cannot be predicted a priori and sometimes the SM
cannot be provided or synthesized in sufficient
amounts for the study.
First of all, it is necessary to know through a
structure–activity relationship study which functional
groups can be modified and used as points of
attachment to the solid support through a linker. The
linker type has a bearing on the success of obtaining
the target proteins and is crucial for diminishing non-
specific binding proteins. An optimal chemical linker
should be mildly hydrophobic so as to prevent auto-
aggregation and also must be long enough to prevent
steric hindrance between the SM and the target protein
(Fig. 2) (Sato et al. 2010).
Recent advances in this field to enhance the
efficiency of affinity purification have been performed
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and in this connection we would highlight the
following linkers: (a) Hydrophilic linkers with PEG
units (Bach et al. 2005; Furuya et al. 2006; Jung et al.
2005; Sato et al. 2007; Tamura et al. 2003; Zhang et al.
2007) or tartaric acid derivatives (Shiyama et al. 2004)
to reduce non-specific binding proteins; (b) ACAP
linkers (aminocaproylaminopentyloxy) to reduce
auto-aggregation resulting from its optimal length,
hydrophobicity and greater rigidity (Guiffant et al.
2007) and (c) elongation of the anterior linkers by
insertion of a rigid polyproline helix for the isolation
of low abundance or low affinity proteins. An example
of this is the isolation of GLO1 as a new target of
indomethacin (Sato et al. 2007).
SMs are immobilized to the matrix by means of
complementary functional groups between the matrix
and the linker. Traditionally, sugar-based affinity
matrices such as agarose or Sepharose have been used
in this approach, Affigel matrices being one of the
most popular affinity matrices; however, these matri-
ces are unstable in organic solvents and also cause
non-specific binding of proteins (Sakamoto et al.
2012). These problems can be solved by using resin-
based affinity matrices due to their stability both in
organic and aqueous media, physical and chemical
stability and high ligand loading capacity. Matrices
based on polymethacrylate derivatives have been
developed as an alternative to Affigel matrices, with
special mention of the matrices known as Toyopearl.
Nevertheless, these matrices often show a high
number of non-specific binding proteins by compar-
ison with Affigel matrices (Sakamoto et al. 2012).
Alternatively, it is possible to immobilize SMs
directly onto the resin using capturable molecules such
as biotin (Fig. 3), which are easily trapped by avidin-
agarose columns (McPherson et al. 2002). The strong
non-covalent interaction between biotin and avidin
results in the essentially non-reversible loading of the
SM onto the resin (Hofmann and Kiso 1976; Hofmann
et al. 1978). This approach has been used to identify
the mitochondrial enzyme OAT (ornithine d amino-
transferase) as the target protein of the antimitotic
marine diazonamide A (Wang et al. 2007).
Once the SM is immobilized on a suitable solid
support it is incubated with a cell lysate or protein
extract, usually by passing the extract through a
column of immobilized material followed by exten-
sive washing to remove non-specific binding proteins.
Finally, the tightly bound proteins are eluted with an
excess of free molecule or under strongly denaturing
conditions using an electrophoresis buffer. These
proteins are analysed by SDS-PAGE 1D (sodium
dodecyl sulphate polyacrylamide gel electrophoresis),
extracted from the gel and the protein bands are
identified by mass spectrometry after partial tryptic
digestion and databases are then searched for com-
parison of mass-sequencing of the digested peptides
(Fig. 4).
On the other hand, as mentioned above, isolation
and identification of target proteins by means of
affinity chromatography is a difficult task because of
the non-specific adsorption of background protein to
the resin and linker. Therefore, several approaches
have been used in order to differentiate between
specific and non-specific interactions.
First of all, it is important to carry out well-designed
negative control experiments. One approach is to use
an inactive analogue of the SM with physical prop-
erties similar to the active SM (Sato et al. 2010; Snyder







Fig. 3 Structure of biotin
Fig. 2 Characteristics of an optimal chemical linker
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inactive chiral isomer or seco-analogue of the active
molecule would serve as an excellent negative control
(Sato et al. 2010) by comparison of proteins eluted
between the active molecule and the inactive ana-
logue. An example is the identification of the target
protein of diazonamide A using a seco-analogue of
this SM (Wang et al. 2007).
Nevertheless, sometimes inactive structural ana-
logues are not available for such study and different
alternative strategies have been developed such as
competitive elution experiments (Emami et al. 2004;
Ito et al. 2010; Sleno and Emili 2008) and serial
affinity chromatography (Yamamoto et al. 2006).
Competitive elution of bound proteins using an
excess of free SM would permit selective elution
under mild conditions; however, the SM’s low water
solubility is a hurdle that needs to be addressed in this
approach. To this end, some hydrophilic organic
solvents such as DMSO have been used to improve the
water solubility of the SM (Sakamoto et al. 2012). One
successful example of selective elution is the isolation
of a cyclic AMP response element-binding protein as a
molecular target of ICG-001, a SM that downregulates
signalling by b-catenin/T cell factor (Emami et al.
2004).
Last, an alternate serial affinity chromatography
approach has been reported where the protein extract
is applied to the immobilized ligand matrix which is
subsequently removed. The fresh matrix is then
incubated with the same lysate (Yamamoto et al.
2006). The first matrix should capture most of the
specific binding proteins due to their high affinity for
the SM while the same amount of non-specific
background proteins should be captured by both
matrices. This approach has been used to identify the
target proteins of FK506, benzenesulphonamide and
methotrexate (Yamamoto et al. 2006) (see Table 1
supporting information).
A great number of small-molecules whose targets
have been identified or confirmed by this approach are
depicted in Table 1 of the supporting information,
which highlights currently the success and widespread
for this approach.
Matrix-free affinity methods
Matrix-free affinity methods rely on the incorporation
of affinity tags to the SM of interest. An affinity tag can
be defined as a compound that imparts an additional
function to the SM to which it is attached. Like matrix-
based affinity methods, the SM must be derivatizable
and maintain at least part of its biological activity. The
most important affinity tags are the fluorophores and
photoreactive groups.
Fluorescence In this approach, the SM bound to
proteins can be visualized in fluorescence gels and the
fluorescence bands identified by mass spectrometry
(Fig. 5). Furthermore, the introduction of a fluorophore
Fig. 5 Scheme of a fluorescence-based affinity experiment
Fig. 4 Scheme of an experiment of affinity chromatography
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to a SM can reveal the subcellular location of the target
proteins. To that end, appropriate lysates with an
enrichment of the target protein can be used reducing
the background levels in protein purification. An
example is the isolation of SF3b as a molecular target
of pladienolide B (Kotake et al. 2007).
One of the most frequently used and studied
fluorophores is the jellyfish green fluorescent protein
(GFP) (Tsien 1998; Zhang et al. 2002). However, the
major drawback of GFP is its huge size (239 amino
acids), sometimes diminishing the activity of the SM
to which it binds.
An alternative is the use of styryl dyes (Garrett and
Fattaey 1999; Sridhar et al. 2000), which span a broad
range of fluorescent emission wavelengths, or the use
of acylphenols as a transfer agent for immunoaffinity
fluorescent tags (IAF) (Hughes et al. 2009).
Some examples of target proteins identified by
fluorescence-based affinity are shown in Table 2 of the
supporting information.
Photoaffinity This approach is commonly used when
the SM has moderate or low affinity for its target
protein(s) (Sadakane and Hatanaka 2006). In order to
bind the SM irreversibly to its target protein a cross-
linking reagent can be used to prevent the dissociation
of weak binders (Leslie and Hergenrother 2008). In a
photoaffinity experiment, a SM with a photoreactive
functional tag and a reporter tag is added to a lysate or
whole cell. The reporter tag is usually a radioactive
isotope (MacKinnon et al. 2007) or biotin which
enables the isolation and identification of target
proteins. In the absence of UV light, the interaction
between the SM and target protein takes place because
the photoreactive group is stable while irradiation of
the photoreactive group at a specific wavelength will
generate a carbene that can produce the covalent
attachment of the SM to the protein target (Leslie and
Hergenrother 2008). Labelled protein mixtures are
separated by denaturing-gel electrophoresis and
detected with a phosphorimager. Specifically labelled
proteins are then isolated and subjected to limited
proteolytic digestion and identified by mass
spectrometry (Fig. 6) (Dormán and Prestwich 2000).
A drawback of this approach is that the SM must
retain biological activity after derivatization with a
photoreactive group. The most frequently used photo-
phores are benzophenones, (Dormán and Prestwich
1994) aryl azides (Fleming 1995; Kotzyba-Hibert et al.
1995) and diazirines (Brunner 1993). However, their
large size can potentially interfere with SM/protein
interactions. Recently, photo-leucine has been used as
a photophore because of its smaller alkyl diazirine side
chains (MacKinnon et al. 2007). In order to maximize
the efficiency of photo cross-linking they incorporated
an alkyne tag instead of biotin to perform an azide-
alkyne cyclo-addition known as ‘‘click chemistry’’
(Cohen et al. 2007; Speers and Cravatt 2004).
Examples of successful target identification by this
approach are shown in Table 3 of the supporting
information.
Drug affinity responsive target stability (DARTS)
Most of affinity-based approaches described above
require derivatization of the SM of interest and it is not
always possible to maintain its biological activity. In
order to overcome this obstacle, a target identification
method known as DARTS has been recently devel-
oped where any SM library can be used without
chemical derivatization or labelling (Lomenick et al.
2009, Lomenick et al. 2011; Nishiya et al. 2009).
DARTS is based on the notion that if a SM binds to
its target protein, the protein-SM complex would be
less susceptible to proteolysis. If the SM is not present,
Fig. 6 Scheme of a photoaffinity experiment
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a protease detects its recognition site(s) on the target
surface initiating a proteolytic attack that leads to the
complete digestion of the target protein.
In this approach, it is not necessary to know the
structure of the SM, and NP extracts can be used
(Lomenick et al. 2011). Furthermore, whereas other
affinity-based approaches utilize positive enrichment
by selectively assembling the target proteins of the
SMs, DARTS uses negative enrichment by digesting
non-target proteins while leaving behind the target
proteins which are resistant to proteases. In a DARTS
experiment, a SM incubated with a protein lysate and a
control protein sample are each treated with varying
amounts of protease and separated by 1D SDS-PAGE.
Then, the bands whose abundance differs between the
two samples are removed, treated with trypsin and
analysed by mass spectrometry (Fig. 7) (Lomenick
et al. 2011).
However, many target proteins can be missed in
this approach because it is necessary to visualize the
enrichment of the target protein in the gel (Lomenick
et al. 2011). In order to solve this difficulty, different
proteomic approaches have been performed to
increase the sensitivity and throughput of this method,
some of which can also be applied to other target
identification methods. Special mention should be
made of the development of 2D-PAGE (O’Farrell
1975), analysis of multiple samples by difference gel
electrophoresis (DIGE) (Unlu et al. 1997) and
advances in multidimensional protein identification
technology (MudPIT) (Washburn et al. 2001).
Another drawback of this approach is the type of
protease chosen which is crucial to maximize the
digestion of all non-target proteins without compro-
mising the protection of the target protein. Currently,
protease mixtures are used and good results are being
obtained with Pronase (Roche), a commercially
available protease mixture capable of digesting both
native and unfolded proteins (Lomenick et al. 2011).
If these drawbacks are solvent, DARTS could be an
alternative to affinity chromatography in the coming
years. Small-molecules whose targets have been
identified or confirmed by this approach are summa-
rized in Table 4 of the supporting information.
Stability of proteins from rates of oxidation (SPROX)
This affinity-based label-free approach is also based
on thermodynamic measurements (West et al. 2010).
In comparison with DARTS, the folding and thermo-
dynamic stability of the target proteins are also studied
but uses the ligand-induced changes in the methionine
oxidation levels for target proteins as the readout
(Lomenick et al. 2011). From an experimental stand-
point, a cell lysate is studied in both the absence and
presence of SM. Both samples are treated with
increasing concentrations of guanidinium hydrochlo-
ride, a chemical denaturant, and the same amount of
H2O2 in order to selectively oxidize the thioether
groups in the side chain of methionine residues.
Finally, a quantitative proteomic analysis is performed
and the target proteins are identified by a change in
protein stability since both samples are identical (West
et al. 2010).
On the other hand, a disadvantage of SPROX is the
fact that only the most abundant proteins in each
sample can be identified and accurately quantified
because there is no a target protein enrichment
mechanism (Lomenick et al. 2011). But the biggest
drawback of SPROX is that the target proteins must
have a methionine-containing peptide and not all
methionine residues have different oxidation rates










Fig. 7 General scheme of a DARTS experiment
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Some examples of target proteins identified by
means of this approach are shown in Table 5 of
supporting information.
Activity-based protein profiling (ABPP)
This approach is based on the response of reactive
functional groups (mainly electrophiles) of SMs with
catalytic residues in the enzyme’s active site (Liu et al.
1999; Sadaghiani et al. 2007). The SMs are comprised
of a reactive group, a linker and a tag. Radioactive
groups, fluorophores such as rhodamine and biotin can
be used as tags to visualize and purify labelled proteins
(Cravatt et al. 2008). Covalent modification can occur
directly using a highly nucleophilic active site residue
or by incorporation of a photoreactive group (i.e.
benzophenone) followed by UV irradiation (Sleno and
Emili 2008).
The protein targets for bioactive SMs are identified
by comparing the labelling reduction when a com-
pound is present (Fig. 8) (Sleno and Emili 2008). The
addition of a SM, either in solution or in vivo, makes
the inhibited target protein(s) less available to
subsequent labelling.
The major advantage of ABPP is the fact that allow
the targeted enzymes to be labelled for purification and
analysis; However, it is necessary the derivatization of
each SM which must contain reactive functional
groups.
Small-molecule probes have been successfully
used for the identification of proteases, lipases,
cytochrome P-450s, glycosidases, kinases and phos-
phatases (Heal et al. 2011; Nomura et al. 2010; Simon
and Cravatt 2010).
Mass spectrometry-based proteomic approaches
Quantitative proteomics have proven to be a powerful
tool for discriminating between protein-SM specific
interactions from background interactions in affinity
experiments (Cheng et al. 2010). Nevertheless, the
absolute intensity of a peptide in a mass spectrum
depends, among other factors, on the type of ionization
thus calling for the use of internal standards. The ideal
internal standard should be a peptide of identical
sequence but labelled with different stable isotopes.
Hence, several strategies based on stable isotope
labelling such as ICAT (isotope-coded affinity tag)
(Gygi et al. 1999; Han et al. 2001; Oda et al. 2003),
iTRAQ (isobaric relative and absolute tag for quan-
tification) (DeSouza et al. 2005; Rix and Superti-Furga
2009; Ross et al. 2004) and SILAC (stable isotope
labelling by amino acid in cell culture) (Ong et al.
2002, 2003, Ong et al. 2009; Yan and Chen 2005) have
been developed for quantitative proteome analysis.
Fig. 8 General scheme of an ABPP experiment
Fig. 9 Scheme of the SILAC technique. This figure is adapted
from Ong et al. (2009)
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The SILAC approach exploits the ability of live
cells to incorporate labelled amino acids through
media supplementation. Proteins will incorporate
either ‘‘light’’, natural isotope abundance forms, or
the ‘‘heavy’’, 13C and 15N-bearing versions of arginine
and lysine amino acids (Ong et al. 2002). Protein
lysates from cultures are incubated either SM-loaded
beads and soluble SM competitor or SM-bead alone.
Then, the samples are combined, separated by SDS-
PAGE and analyzed by mass spectrometry. Proteins
interacting directly with the SM will be enriched in the
heavy state over the light and will be identified by
differential ratios. Non-specific interactions of pro-
teins will be enriched equally in both states and will
have the same isotopic ratio (Fig. 9) (Ong et al. 2009).
The molecular targets of several kinase inhibitors
have been identified by SILAC (Ong et al. 2009) (see
Table 6 supporting information).
A disadvantage of this method is that requires at
least five populations to satisfactorily incorporate the
isotopic labels and can only be used with biological
samples grown in culture (Ong et al. 2003; Yan and
Chen 2005). An alternative is the ICAT technique
which is a gel-free approach enabling the quantifica-
tion of proteins in any biological system (Roti and
Stegmaier 2012). This approach uses a chemical
reagent containing a biotin affinity tag for selective
purification, a linker that incorporates stable isotopes
and an iodoacetamide reactive group that specifically
reacts with cysteinyl thiols (Yan and Chen 2004). In an
ICAT experiment, a protein lysate incubated with the
SM bound to an affinity matrix and the same lysate
incubated with a molecule control are labelled in vitro
with heavy (d8) and light (d0) ICAT reagents,
respectively (Fig. 10). Then, both protein mixtures
are combined, digested with trypsin into peptides and
subjected to avidin affinity chromarography to enrich
the labelled peptides that carry biotin tags in order to
reduce the complexity of the mixtures. Finally, the
labelled peptides are isolated, identified by their
differences in the isotopic distribution and quantified
using LC–MS.
Several target proteins of anticancer E7070 have
been identified using this approach (Oda et al. 2003).
Although the ICAT approach drastically reduces
the complexity of the mixture, only 96 % of human
proteome possesses cysteine residues (Zhang et al.
2004). To overcome this difficulty, an amine group-
based methodology known as iTRAQ has been
developed by Ross et al. (2004). This in vitro gel-
free approach utilizes isobaric reagents composed of a
reporter group, a balance group and a reactive group
that reacts specifically with primary amine groups of
peptides (Fig. 11). The reporter group is a 4-methyl-
piperazinyl tag with a mass ranging from 114 to
117 Da according to the different isotopic
Fig. 10 Scheme of the
ICAT technique
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combinations of 12C/13C and 16O/18O in each individ-
ual reagent. A carbonyl group with a mass range
between 28 and 31 Da is used as balancer group in
order keep the combined mass of the reporter and
balance groups constant at 145 Da for all four
reagents. The reporter group is fragmented into ions
from 114 to 117 Da in MS/MS experiments and the
intensity of these fragments is used for quantification
of up to four simultaneous samples (Yan and Chen
2005). In an iTRAQ experiment, a lysate incubated
with the SM bound to an affinity matrix and the same
lysate incubated with a molecule control are labelled
in vitro each with a different iTRAQ reagent. Then,
labelled peptides in both samples are combined and
analyzed by LC–MS/MS and the target proteins are
identified by their differences in the isotopic distribu-
tion (Fig. 11).
Recently, a kinobead matrix has been developed to
evaluate the selectivity of several kinases by iTRAQ
(see Table 7 of the supporting information) (Bant-
scheff et al. 2007).
Genetic methods to identify the molecular target
Genetic-based methods study the SM targets/path-
ways from the physiological responses or biochemical
signatures produced by the SMs (Lomenick et al.
2009). We classify the genetic-based methods into the
following groups: expression-cloning-based methods
(Terstappen et al. 2007), microarray technologies
(Sleno and Emili 2008), gene overexpression tech-
niques (Luesch et al. 2005) and synthetic lethality
approaches (Lum et al. 2004).
Expression-cloning-based methods
These approaches are based on the expression of target
proteins from cDNA libraries. To solve the problems
associated with the low abundance of target proteins,
these methods include an affinity step to increase their
quantity and facilitate their purification and isolation.
Nevertheless, because the target proteins are
expressed on the basis of fusion constructs of cDNA
libraries, their properties might be different from those
of their native counterparts and this could affect
binding to the SM (Terstappen et al. 2007). Moreover,
these methods are usually limited to yeast or other
simple well-characterized model organisms.
The following approaches have been applied for the
identification of target proteins: yeast and mammalian
three hybrid systems, phage display, mRNA display
and Drug westerns (Tanaka et al. 1999).
Yeast three hybrid (Y3H) and mammalian three hybrid
systems The use of yeasts is widely used for the
identification of target proteins, being Saccharomyces
cerevisiae an organism model of simple eukaryotes
given that its genome can easily be manipulated
(Bjornsti 2002; Forsburg 2001).
Y3H is currently a promising approach for the
identification of target proteins (Licitra and Liu 1996),
which is comprised of three components: a synthetic
hybrid ligand and two hybrid fusion proteins. One of
the hybrid fusion proteins is composed of a DNA
binding domain (LexA) fused generally to dihydrofo-
late reductase (DHFR), a target of methotrexate
(MTX), which acts as a ligand binding domain (Abida
et al. 2002; Baker et al. 2003; Lin et al. 2000). The
Fig. 11 Scheme of the
iTRAQ approach
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other fusion protein contains a transcriptional activa-
tion domain, usually derived from the yeast transcrip-
tion factor GAL4 (Henthorn et al. 2002), fused to a
cDNA library that includes the potential target
proteins (Becker et al. 2004). The synthetic hybrid
ligand is a SM that is covalently linked through a
spacer to a ligand, usually MTX, in order to connect
the first hybrid fusion protein to the second. From an
experimental standpoint, a yeast strain that expresses
DHFR is transformed with a library of cDNAs fused to
a transcriptional activation domain. Then, the hybrid
ligand is added to yeast and, if a binding protein is
present in the library, the hybrid ligand will attach the
transcriptional activation domain to the DNA activat-
ing expression of the reporter gene which is measured
as the assay signal. Cells that express the reporter gene
are selected and their DNA is extracted and sequenced
in order to identify the potential target proteins by
means of sequence-similarity searches (Fig. 12)
(Becker et al. 2004).
Successful examples of identification of target
proteins by Y3H are shown in Table 8 of the
supporting information.
Unlike other expression cloning approaches the
interaction between SMs and target proteins occur in
living cells (Terstappen et al. 2007). Nevertheless, this
approach can not be used directly in mammals due to
differences in regard to yeast proteins. In order to
solve this limitation, the MASPIT system (Mamma-
lian Small Molecule Protein Interaction Trap) has
been developed (Caligiuri et al. 2006). This is based on
the associated JAK cytokine-receptor (janus-activated
kinase)-STAT (signal transducer and activator of
transcription) signal transduction system (Terstappen
et al. 2007).
One successful example of MASPIT system in
mammals is the identification of ephrin receptor
tyrosine kinases and cyclin G-associated kinase of
the ABL tyrosine kinase inhibitor PD173955 (Fig. 13)
(Caligiuri et al. 2006).
mRNA display This approach utilizes mRNA display
to identify proteins bound to a SM of interest
(McPherson et al. 2002). Amplification by PCR
(polymerase chain reaction) (Fig. 14 step 1) of a
cDNA library with primers that introduce sequences
permits in vitro transcription (Fig. 14 step 2). Then,
the mRNAs generated are ligated to a puromycin-
DNA linker (Fig. 14 step 3) and the in vitro translation
is carried out to generate protein-mRNA fusion
molecules (Fig. 14 step 4) (Liu et al. 2000;
Terstappen et al. 2007). The complexes obtained are
purified and reverse transcribed to generate a stable
cDNA template (Fig. 14 step 5). Then, the biotin-
labelled SMs of interest are immobilized on solid
support and incubated with mRNA display molecules
(Fig. 14 step 6) (Terstappen et al. 2007; Tochtrop and
King 2004). Binding proteins are purified using avidin
chromarography by elution with free biotin. After
elution of the binding proteins (Fig. 14 step 7), the
cDNAs are amplified by PCR (Fig. 14 step 1) resulting
again in a cDNA library that is rich in target proteins.
Finally, after several iteration processes, the cDNAs
are purified, sequenced and the target protein
identified by means of a DNA sequence similarity
search (Hammond et al. 2001).
The major advantage of this approach is that the
amplification process should permit the identification
of low abundance targets by repetitive rounds of
affinity selection; however, iterative rounds of ampli-
fication may promote the identification of short-length
products rather than their full-length counterparts
(Terstappen et al. 2007).
Fig. 12 Scheme of the Y3H approach






Fig. 13 Structure of PD173955
Phytochem Rev (2013) 12:895–914 905
123
To our knowledge, this method has only been
successful with an immobilized conjugate of FK506-
biotin to identify full-length FKBP12 (McPherson
et al. 2002).
Phage display This approach has emerged as a valid
approach to identify target proteins of SMs using the
display of proteins on bacteriophages such as M13, T4
and T7, which enable the extraction of proteins from
large libraries whereby a cDNA library is expressed
with bacteriophage coat proteins (Kay et al. 1996;
Sche et al. 1999). The phage library obtained is then
exposed to the biotinylated immobilized SM resulting
in the capture of bacteriophages that have affinity for
the SM (Fig. 15 step 1) (King 1999). Next, an
extensive wash is done to minimize non-specific
interactions between some of the bacteriophage coat
proteins and agarose column and the binding
bacteriophages are eluted selectively with excess of
biotin (Fig. 15 step 2) and transfected into bacterial
host cells (Fig. 15 step 3) (usually E. coli) for
amplification (Fig. 15 step 4) (Das et al. 2011;
Terstappen et al. 2007). Phage populations obtained
are re-exposed to immobilized SMs and are subjected
to several rounds of affinity enrichment (Fig. 15 step
5) (Jung et al. 2009). Finally, a monoclonal phage
population is obtained and the target proteins are
identified by DNA sequence-similarity searches
(Terstappen et al. 2007).
In general, low-abundance targets and targets of
low-affinity SM can be identified by iterative ampli-
fication steps; however, in practice is usually compli-
cated because clones that express high-affinity
proteins will dominate the phage population. Another
disadvantage of this approach is the fact that it is
necessary to use a labelled-SM.
Fig. 14 General scheme of
the mRNA approach. This
figure is adapted from
Tochtrop and King (2004)
Fig. 15 Scheme of the phage display approach
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Several successful examples of target protein
identification using this approach are shown in
Table 9 of the supporting information.
Drug westerns Tagged SMs are used in this approach
to electrophoretically probe cDNA expression
libraries (Tanaka et al. 1999). In this experiment, a
plaque consisting of one member of a cDNA library is
observed when bacteriophages are grown in a Petri
dish together with the cDNA library (Chang 2009; Das
et al. 2011). Proteins from the plaque are transferred to
a nitrocellulose membrane where they are screened
against labelled SMs with an antigen (BSA or FITC).
Hits obtained from the plaques are detected by
enhanced chemiluminescence, a single virus is
isolated and purified and the target proteins are
identified by DNA sequencing method (Fig. 16).
This method can facilitate immediate cloning of the
genes encoding drug-binding proteins. However, as in
other approaches, a limiting aspect of Drug westerns is
the fact that a labelled SM is required.
An example of the application of Drug westerns
method is the isolation of the transcription factor NF-
YB and Thymosin b-10 as target proteins of the
anticancer small molecule HMN-154 (Fig. 17) (Ta-
naka et al. 1999).
Microarray technologies
Miniaturized high-density arrays with immobilized
proteins or cDNA (microarrays) can be used in high-
throughput assays in order to identify the targets of the
SMs. Protein microarrays and DNA microarrays have
been developed for this purpose.
Protein microarrays In this approach the binding
profile of a SM for an entire proteome can easily be
obtained in a short period of time (Sleno and Emili
2008; Terstappen et al. 2007). A set of proteins are
purified and immobilized by amino-terminal
glutathione S-transferase (GST) tag on a glass
microscope slide or some other derivatized surface
(Heng et al. 2001; Heng and Snyder 2003). The
microarray is then incubated with a labelled form of
the SM, usually biotin. After thorough washing, bound
targets are detected by adding a streptavidin
fluorescently labelled conjugate and then the labelled
proteins are identified by their positions on the
microarray. As a loading control, the microarray is
probed with GST-specific antibodies (Fig. 18) (Sleno
and Emili 2008; Terstappen et al. 2007).
The major advantage of this method is that it allows
for equal exposition of all proteins to the SM.
Furthermore, proteins can be attached to chemically
modified porous silicon and, after the addition of SMs,
the bound substrates can be selectively monitored
using techniques such as DIOS (direct ionization on
silicon) (Shen et al. 2001) or MALDI-TOF.
Successful of this approach will be increased with
the development of label-free binding detection com-
patible with the proteome array format.
On the other hand, this approach only reproduces
the binding in vitro meaning that some proteins, whose
affinity for the SM is due to post-translational
modifications or their involvement in a complex
formation with other proteins, might not be identified.
Moreover, depending on the positioning of the protein
on the chip, the SM might not bind to its target protein
due to steric hindrance (Terstappen et al. 2007).
Some successful examples of this approach are
shown in Table 10 of supporting information.
DNA microarrays This approach, known as ‘‘reverse
transfected’’ cell microarrays, is based on the
expression of defined cDNAs avoiding the use of
individually purified proteins (Ziauddin and Sabatini






Fig. 17 Structure of HMN-
154
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2001) since the glass slides are imprinted with sets of
specific cDNAs in expression vectors, overlaid with a
transfection reagent and covered with mammalian
cells in a culture medium. Transfected cells will
express cDNAs at a defined location on the chip and
the target proteins will be revealed by the addition of a
fluorescent or radioisotope-labelled SM to the chip
and subsequent DNA sequence-similarity searches
(Fig. 19) (Terstappen et al. 2007).
The major disadvantage of this approach is that the
sensitivity of detection might be compromised for
some cell types since transfection efficiencies can be
relatively slow (Terstappen et al. 2007).
FKBP12 has been identified by DNA microarrays
when radiolabelled FK506 is added to the culture
medium of HEK293T cells (Ziauddin and Sabatini
2001).
Gene overexpression techniques
This technique is based on the principle that gene
overexpression results in increased protein product,
and if this protein is targeted by a SM, the cell should
gain resistance to that SM (Luesch et al. 2005). This
approach uses DNA libraries which are transformed
by a yeast strain and the products obtained are grown
on media containing the SM at a concentration that
inhibits wild type growth. Target proteins are identi-
fied from drug-resistant transformants by means of
sequencing of plasmid DNA (Fig. 20) (Bharucha and
Kumar 2007).
However, the main disadvantage of this approach is
that SMs often exhibit lower permeability in yeast
cells than in mammalian cells.
Several successful examples of target protein
identification using this approach are shown in















Fig. 19 Scheme of the DNA microarrays approach. This figure
is adapted from Terstappen et al. (2007)
Fig. 20 General scheme of gene overexpression. This figure is
adapted from Bharucha and Kumar (2007)
Fig. 18 Scheme of the protein microarrays approach. This figure is adapted from Terstappen et al. (2007)
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Synthetic lethality
This genetic approach uses collections of heterozy-
gous mutants and studies their hypersensitivity to SMs
(Giaever et al. 1999; Lum et al. 2004). The availability
of the genome-wide collection of heterozygous yeast
deletion strains is allowing the systematic application
of this methodology.
It is often assumed that the reduction of the gene
copy number of a target protein can result in sensiti-
zation to the small molecule of interest. Genomic
DNA from cultures before (G = 0) and after twenty
generations of growth (G = 20) are isolated, ampli-
fied by PCR and hybridized to DNA microarrays
(Tochtrop and King 2004). Target proteins are iden-
tified by their ability to confer resistance to a strain
when present at high copy (Fig. 21).
This approach has the advantage that a free-label
SM can be used.
However, hypersensitivity may can due both direct
and indirect mechanism, so other techniques will be
required in order to confirm the molecular target of
each SM (Tochtrop and King 2004). Moreover, only
can be used SM that affect cell growth/viability.
Several successful examples of target identification
using this approach are shown in Table 12 of the
supporting information.
Other methods
Despite the fact that genetic and affinity-based meth-
ods have successfully contributed to the identification
of a large number of target proteins, these methods
cannot be applied in a general manner due the nature
of each ligand and target protein and it is necessary to
investigate and develop new methods for the elucida-
tion of biological targets. In this section, we will
discuss the identification of targets using different
basis to those described above.
Biochemical suppression
This method is based on the functional suppression of
protein activity by chemical inhibitors by in vitro
reactions regardless of the affinity that the SM has for
its target protein (Peterson et al. 2006; Terstappen
et al. 2007). From an experimental standpoint, an
activity assay is used to measure the inhibition
produced in a protein extract when a SM that inhibits
the activity of interest is added. Fractions of uninhib-
ited extract are added to the inhibited extract to
identify the fraction that suppresses the SM’s inhib-
itory activity. This process is repeated until the protein
that suppresses the inhibition is purified and identified
by gel electrophoresis and mass spectrometry
(Fig. 22) (Terstappen et al. 2007).
The major advantages of this approach are that it
does not require modification of the SM and small
amounts of proteins can be identified because this
method is not based on affinity. Furthermore, sup-
pressors are introduced as native protein forms rather
than individual gene products, allowing for identifi-
cation not only of the target proteins but also of other
pathway components (Terstappen et al. 2007).
Fig. 21 Scheme representative of the synthetic lethality
approach. This figure is adapted from Tochtrop and King (2004)
Fig. 22 Scheme of the biochemical suppression method. This
figure is adapted from Peterson et al. (2006)
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However, this method needs to use protein fractions
which is a drawback for intact cells which would need
to be permeabilized (Terstappen et al. 2007).
Although this approach might be a good alternative
to affinity-based methods, to our knowledge, it has
only been identified the Cdc42–RhoGDI (Rho-GDP
dissociation inhibitor) complex as a direct target of
pirl1 (Fig. 23) and the Arp 2/3 (actin and related
proteins) complex as a downstream component of the
actin assembly pathway that is capable of relieving
upstream inhibition of Cdc42–RhoGDI when it is
added at high concentrations (Peterson et al. 2006).
Target validation assays
Once a target protein is identified, the next step is to
make certain that its modulation is associated with the
phenotype observed in the assay where the SM was
identified (Terstappen et al. 2007). There are several of
approaches and tools available to discriminate
between true interactions and false positives (Kramer
and Cohen 2004) of which we would highlight
bioinformatic analysis, if the three-dimensional pro-
tein structure is available (Macchiarulo et al. 2004;
Mueller et al. 2007), study of the physical interaction
of the SM and the putative target by surface plasmon
resonance (Boozer et al. 2006; Elinder et al. 2011;
O’Connell et al. 2010), fluorescence anisotropy
(Zhang et al. 2011), isothermal titration calorimetry
(Buurman et al. 2011; Zhou et al. 2008) or resonance
acoustic profiling (Li et al. 2006) and the use of cell
culture validation experiments such as RNA interfer-
ence (RNAi) and overexpression of the target protein.
Concluding remarks and future prospects
NPs play an important role in the discovery of new drugs
and agrochemicals owing to their great chemical diver-
sity, high affinity and specificity for biological targets.
Understanding the mechanism of action of bioactive
compounds and identifying their molecular targets, are
still the most important challenges facing chemical
genetics. Despite the great variety of new methods that
have been developed over the last several years, affinity
chromatography is still the most widespread and
successful method for identifying the target proteins of
bioactive-small molecules. Proof of this is the dispro-
portionately large number of target proteins identified by
affinity chromatography highlighted in this review in
comparison with the rest of the techniques.
Recent advances in mass-spectrometry proteomic
methods such as SILAC, ICAT and iTRAQ, together
with proteomic approaches such as 2D-PAGE, DIGE
or MudPIT, have enabled a distinction to be drawn
between specific and nonspecific binders and will help
to identify low abundance targets with a low-affinity
small molecule by affinity chromatography. More-
over, subcellular localization of the small molecule by
means of fluorescence probe could be used for affinity
purification in order to decrease sample complexity.
However, affinity chromatography is limited to SM
that contain derivatizable functionalities and whose
bioactivity is unaffected by modification, which is a
serious hurdle. Future advances in new techniques
should avoid the derivatization or labelling of SMs and
should allow their application to protein extracts and
membrane proteins.
In this context, DARTS has emerged as a promising
alternative to circumvent the drawbacks outlined
above. Nevertheless, new experimental conditions
and new advances in degradomics must be developed
in order to decrease the number of proteolysis
conditions that need to be tested for each SM. Free-
label protein microarrays could be used simulta-
neously with DARTS to study a whole proteome.
Further identification of new target proteins using
these approaches will prove whether they are suited
for widespread use.
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